MedPath

SLV-342

Generic Name
SLV-342

First in Man Study With SLV342

Phase 1
Terminated
Conditions
Pharmacokinetics
Interventions
Drug: placebo
First Posted Date
2009-09-28
Last Posted Date
2011-08-25
Lead Sponsor
Abbott Products
Target Recruit Count
48
Registration Number
NCT00985478
Locations
🇬🇧

Site Reference ID/Investigator# 61142, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath